Phase 1 study of EGFR ‐antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives

Cancer, EarlyView.

Source: Cancer - October 6, 2018 Category: Cancer & Oncology Authors: Julie E. Bauman, Umamaheswar Duvvuri, Sufi Thomas, William E. Gooding, David A. Clump, Brian Karlovits, Ahmad Wehbe, Frank R. Miller, Seungwon Kim, Malabika Sen, Dwight E. Heron, Jennifer R. Grandis, Athanassios Argiris Source Type: research